Characteristics of Hospitalized Patients With Community-acquired Pneumonia
A Retrospective Study on Disease Characteristics of Hospitalized Patients With Community-acquired Pneumonia
1 other identifier
observational
200
1 country
1
Brief Summary
At present, the epidemiological characteristics and the distribution of pathogens of community-acquired pneumonia in Shandong Province are not clear. In order to understand the characteristics of community-acquired pneumonia, the distribution of pathogens and the risk factors of complications in Shandong Province, it is necessary to carry out investigation and study, which will provide the basis and support for the future prospective cohort study of pulmonary infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2023
CompletedStudy Start
First participant enrolled
September 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2024
CompletedOctober 10, 2023
October 1, 2023
1 year
September 22, 2023
October 6, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The prevalence of CAP
The prevalence of CAP
Up to 12 months
Secondary Outcomes (2)
Severity Assessment: Curb-65
Up to 12 months
Sputum culture
Up to 12 months
Interventions
Without intervention
Eligibility Criteria
All patients aged over 14 years with community-acquired pneumonia were confirmed by imaging.
You may qualify if:
- Age \> 14 years.
- In the community.
- Chest X-ray showed patchy, patchy infiltrative shadows or interstitial changes with or without pleural effusion (in or out of hospital) .
- Pneumonia-related clinical manifestations: 1) recent cough, expectoration or respiratory disease symptoms aggravated, and the emergence of purulent sputum, with or without chest pain. 2) fever: armpit temperature ≥37.3℃ or hypothermia: armpit temperature \<36℃. 3) signs of pulmonary consolidation and/or Wet Rales. 4) white blood cell \> 10 × 10\^9/L or \< 4 × 10\^9/L with or without left shift of nucleus. Comply with 1,2,3 above plus any one of 4 above.
You may not qualify if:
- The patients were initially diagnosed with pulmonary neoplasms, tuberculosis, non-infectious interstitial disease, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophil granulocyte infiltration and pulmonary vasculitis.
- Human Immunodeficiency Virus.
- The patient was readmitted within 72 hours of discharge and was classified as a single hospitalization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
Jinan, Shandong, 250014, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 22, 2023
First Posted
October 4, 2023
Study Start
September 22, 2023
Primary Completion
September 22, 2024
Study Completion
September 22, 2024
Last Updated
October 10, 2023
Record last verified: 2023-10